# A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary Small Vessel Disease

> **NCT03376646** · NA · COMPLETED · sponsor: **DK Medical Technology (Suzhou) Co., Ltd.** · enrollment: 277 (actual)

## Conditions studied

- Coronary Small Vessel Disease

## Interventions

- **DEVICE:** Cohort A: Dissolve™
- **DEVICE:** Cohort A: Resolute™ Integrity
- **DEVICE:** Cohort B: Dissolve™-2.00mm

## Key facts

- **NCT ID:** NCT03376646
- **Lead sponsor:** DK Medical Technology (Suzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-20
- **Primary completion:** 2020-01-10
- **Final completion:** 2024-04-15
- **Target enrollment:** 277 (ACTUAL)
- **Last updated:** 2025-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03376646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03376646, "A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary Small Vessel Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03376646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*